Hall, Rasheeda K. http://orcid.org/0000-0002-3057-4828
Cary, Michael P. Jr. http://orcid.org/0000-0002-7966-7515
Washington, Tiffany R.
Colón-Emeric, Cathleen S. http://orcid.org/0000-0001-7681-8624
Funding for this research was provided by:
National Institute on Aging (P30AG028716, R03AG050834, K76AG059930, K24AG049077-01A1, P30 AG028716, P30 AG028716)
National Center for Advancing Translational Sciences (KL2TR002554, UL1TR002378)
Doris Duke Charitable Foundation (2015207)
Article History
Accepted: 23 October 2019
First Online: 5 November 2019
Compliance with ethical standards
:
: CCE acknowledges the following disclosures: acting as a consultant for Novartis and Amgen (DSMB Chair, CEC Chair); use of patents for bisphosphonate medications in cardiovascular indications; Co-owner Biscaria Inc.—studying non-bone uses of bisphosphonate medications. MPC acknowledges the following disclosures: receipt of royalties from an UpToDate online article that he co-authored. RKH and TRW have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Duke University Institutional Review Board Protocol ID Pro00063355) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.